Quest Diagnostics cash flow statement
In fiscal 2025, Quest Diagnostics's operations generated $1.89bn of cash; it spent $527m on capital projects, leaving free cash flow of $1.36bn. It returned $353m in dividends and $450m through buybacks.
Cash flow statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 997 | 1,118 | 895 | 1,187 | 652 | 944 | 821 | 1,116 | 1,175 | 1,200 | 1,243 | 2,005 | 2,233 | 1,718 | 1,272 | 1,334 | 1,886 | 1,951 |
| Depreciation and amortisation | 257 | 254 | 281 | 287 | 283 | 314 | 304 | 249 | 270 | 309 | 329 | 361 | 408 | 437 | 439 | 493 | 570 | 585 |
| Stock-based pay | 75 | 54 | 72 | 50 | 28 | 51 | 52 | 69 | 79 | 61 | 56 | 97 | 79 | 77 | 77 | 88 | 88 | 88 |
| Capital spending | 167 | 205 | 161 | 182 | 231 | 308 | 263 | 293 | 252 | 383 | 400 | 418 | 403 | 404 | 408 | 425 | 527 | 576 |
| Free cash flow | 830 | 913 | 734 | 1,005 | 421 | 636 | 558 | 823 | 923 | 817 | 843 | 1,587 | 1,830 | 1,314 | 864 | 909 | 1,359 | 1,375 |
| Free cash flow after stock pay | 755 | 859 | 662 | 955 | 393 | 585 | 506 | 754 | 844 | 756 | 787 | 1,490 | 1,751 | 1,237 | 787 | 821 | 1,271 | 1,287 |
| Dividends paid | 75 | 71 | 65 | 108 | 185 | 187 | 212 | 223 | 247 | 266 | 286 | 297 | 309 | 305 | 314 | 331 | 353 | 369 |
| Share buybacks | 500 | 750 | 935 | 200 | 1,037 | 132 | 224 | 590 | 465 | 322 | 353 | 325 | 2,199 | 1,408 | 275 | 151 | 450 | — |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 464 | 314 | 544 | 563 | 465 | 278 | 597 | 611 |
| Depreciation and amortisation | 135 | 140 | 143 | 142 | 145 | 147 | 146 | 147 |
| Stock-based pay | 27 | 22 | 21 | 20 | 25 | 20 | 23 | 20 |
| Capital spending | 123 | 117 | 108 | 144 | 158 | 114 | 138 | 166 |
| Free cash flow | 341 | 197 | 436 | 419 | 307 | 164 | 459 | 445 |
| Free cash flow after stock pay | 314 | 175 | 415 | 399 | 282 | 144 | 436 | 425 |
Compare with peers
- DaVita cash flow
- Labcorp cash flow
- Brightspring Health Services, Inc. cash flow
- Agilon Health, Inc. cash flow
- Option Care Health, Inc. cash flow
Head to head: DGX vs DVADGX vs LHBTSG vs DGX
More: Health Care Services stocks compared, Health Care sector, rankings of US companies